Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Repatha Device Usability in Hypercholesterolemia
NCT01849497Phase 3Completed
- Sponsor
- Amgen
- Start
- Apr 2013
- Primary completion
- Sep 2013
- Countries
- 2
01
Overview
A Phase 3 trial of evolocumab in hypercholesterolemia, mixed dyslipidemia, sponsored by Amgen. Started Apr 2013; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT01849497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849497.